This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Avm Biotechnology, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Iain Duncan: Innovator in Pharmaceutical Formulations
Introduction
Iain Duncan is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of glucocorticoids. His innovative work has the potential to improve the efficacy and safety of glucocorticoid treatments.
Latest Patents
Iain Duncan holds a patent for a stable glucocorticoid formulation. This invention relates to aqueous pharmaceutical formulations comprising a glucocorticoid. These formulations are designed to contain high concentrations of glucocorticoid while reducing the levels of preservatives. This advancement is crucial for enhancing the therapeutic effectiveness of glucocorticoids.
Career Highlights
Iain Duncan is currently associated with Avm Biotechnology, LLC, where he continues to develop innovative pharmaceutical solutions. His work focuses on improving drug formulations to better serve patients' needs.
Collaborations
Iain collaborates with Adalbert Jarzyna, contributing to the advancement of pharmaceutical technologies. Their combined expertise fosters innovation in the field.
Conclusion
Iain Duncan's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work on glucocorticoid formulations is a testament to the importance of research and development in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile